Calkins Daniel reported grant involving 8,333 shares of Verastem, Inc. at $0.00 for $0 on Sep 30, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Chief Financial Officer
Chief Financial Officer
Filed Oct 2, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$0Shares × reported price
Shares traded
8,333Common Stock
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
126,347Direct
Trade date
Sep 30, 2026Grant
Filed
Oct 2, 2026, 5:15 PM ET2-day reporting delay
Accession
0001104659-26-113361Code A · Transaction 235406
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Oct 1, 2026Sell2,566$8.00−$20,528Trade 235407
2 transaction rows in this filing. Joint filers share the same rows.

VSTM price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
VSTM · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −6.2%1w ago +6.2%1d ago +2.9%
Returns since7d +8.8%30d +27%90d180d1y

Footnotes in full

F1: The reported securities were subject to a performance restricted stock units ("RSU") award that was granted on January 21, 2026. 106,893 RSUs vested on September 30, 2026, upon the Issuer's Compensation Committee of the board of directors determining the performance criteria related to certain clinical development goals had been achieved. F2: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of RSUs.